Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (13154)	9/27/2004 11:16:25 PM
From: hmpa	Read Replies (1) \| Respond to of 52153

1067 is monosuccinic acid ester of the Probucol, old and known anti-oxidant. This derivatization make Prubucol water soluble. Now they are talking about anti-inflammatory property, down-regulation of the VCAM-1. Everyone is entitled to his/her opinions, but AGI-1067 is as water-insoluble as probucol. Metabolically all AGI probucol monosubstituted derivatives (at least 4 I know about) are very different from probucol and different from each other.

To: Miljenko Zuanic who wrote (13154)	9/28/2004 1:52:33 AM
From: zeta1961	Read Replies (1) \| Respond to of 52153

>>And that is….????<< How it was able to move the pps within minutes in after hours..now, that's a strong drug!<g> <<Now, what about lumina volume and area?>>> the buck stops there(lumina) so to speak..will watch from the side lines for free..thanks Miljenko for reminding us that it was a Probucol modification..will have to do more homework..I still don't think those results although statistically significant, were anything to get excited about as a 'final product'..the quote where a physician stated, "great proof of concept" told me something..OTOH..alot of longs are happy tonight! Zeta